MAO-B-IN-56
MAO-B-IN-56 is a multi-target-directed ligand with AChE, BChE, MAO-B, and BACE1 inhibitory activity, with IC50 values of 0.35 μM, 3.22 μM, 0.14 μM, and 3.85 μM respectively, and shows selectivity for AChE over BChE and MAO-B over MAO-A.MAO-B-IN-56 reduces amyloid-beta production, reduces paw edema, improves spatial memory, and enhances Alzheimer's disease hallmarks and associated histopathological alterations.MAO-B-IN-56 can be used for the research of alzheimer's disease.
For research use only. We do not sell to patients.
- Formula: C26H26N6O5S
- Molecular Weight:534.59
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
AChE 0.35 μM (IC50) |
BChE 1.55 μM (IC50) |
BACE1 3.85 μM (IC50) |
MAO-A 0.85 μM (IC50) |
MAO-B 0.14 μM (IC50) |
COX-2 7.83 μM (IC50) |
MAO-B-IN-56 (0.026 mmol/kg, administered daily) effectively ameliorates streptozotocin (STZ) (HY-13753)-induced Alzheimer's disease pathology in mice, enhances spatial memory, maintains hippocampal structural integrity, and normalizes key Alzheimer's disease (AD)-related biochemical parameters, but fails to restore recognition memory indicators in the novel object recognition (NOR) test[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
Chemical Information
-
Molecular Weight 534.59
-
Formula C26H26N6O5S
-
SMILES
COC1=CC=C(NC(CN2C=C(/C=N\NC(CNC3=CC=C(S(=O)(N)=O)C=C3)=O)C4=C2C=CC=C4)=O)C=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)